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Neurosurgery: Expanding Relevance in the Evolution of Medicine? 
 
The field of neurosurgery has enjoyed an enviable position among medical specialties over the 
past decades.  In most parts of the world, including North America, virtually all neurosurgeons have 
been able to expect to fulfill fundamental material needs quite quickly after training.  In addition, most 
have been able to function autonomously, with modest oversight from colleagues, other medical 
practitioners, and administrators.  Finally, neurosurgeons have felt comfortable with the general 
importance of the specialty in the medical realm.  Over the past decade, tremendous changes are 
evident across the medical landscape globally.  Perhaps the one remaining constant may be the severity 
and dramatic nature of the diseases that neurosurgery treats, preserving the potential for 
neurosurgeons to singularly change the life course of select patients.  However, is this enough to 
maintain neurosurgery’s importance, particularly when many of these changes directly undermine 
factors that have contributed to its success?   
The success of neurosurgery has been predicated upon several key factors, but tremendous 
change evident in each.  First, much of medicine’s initial understanding of the nervous system was based 
primarily on anatomy.  Among the medical specialties of the clinical neurosciences of neurosurgery, 
neurology, and psychology, ours is uniquely grounded in such consideration.  In the past decades, the 
fundamental knowledge of the nervous system is increasing at all levels of resolution, including 
subcellular, single neuron, neural circuits and populations of neurons, functional brain regions, and 
ultimately behavior.  The primary conversation is rapidly shifting from anatomy to underlying genomic 
and proteomic features of diseases.  Furthermore, integrated function is being studied by functional 
MRI, as well as electrical and magnetic source imaging, leading to efforts to directly improve 
neurological function as the primary goal of treatment.  While this shift in focus has not entirely 
disenfranchised considerations of anatomy, neurosurgery’s voice in the dialogue has most definitely 
been joined by that of many other disciplines, even related to traditionally “neurosurgical” diseases.  
Perhaps even more importantly, the increasing knowledge of the nervous system diseases and potential 
to treat functional disorders is now poised to dramatically shift the entire attention of the clinical 
neuroscience world.  Consider for example the direct and indirect costs associated with Alzheimer’s 
disease as the world’s population ages, autism, depression, post-traumatic stress disorder that costs the 
lives of multiple American veterans a day, and the increasing focus on mild traumatic brain best 
highlighted by recent discussions on American football.  What role will neurosurgery play in the 
treatment of these diseases? 
For a large part of its evolution, neurosurgery has been successful in controlling the treatment 
of specific disease entities, leaving the bulk of other diseases to neurologist and psychiatrists.  This has 
had the effect of minimizing competition from other disciplines for patients, as well as reducing 
unfavorable and unsympathetic oversight.  However, dramatic changes are evident in how physicians 
are organized to treat diseases.  In contrast to the traditional paradigm of individual physicians treating 
patients, many disease entities are now being treated by multidisciplinary teams of specialists.  In many 
modern centers, patients with neurovascular diseases are managed by the cerebrovascular and stroke 
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services that comprise of neurosurgeons, neurologists, intensivists, and radiologists.  Epilepsy and 
functional neurosurgery programs are organized in much the same way, as are neuro-oncology 
programs.  In other cases, non-neurosurgeons can now offer competing treatments for our patients.  
Orthopedic surgeons have competed for spine patients for decades, but this phenomenon is also 
evident in endovascular, where neurologists now comprise a large percentage of new trainees in 
neurointerventional techniques.  In profound ways, developments in stereotactic radiosurgery have 
changed the flow of brain tumor patients, with modern frameless methods allowing radiation 
oncologists to treat patients without neurosurgical input, using technology originally developed by 
neurosurgeons.  In many hospitals, the flow of patients in the neuro ICU has also shifted, with 
neurocritical care neurologists playing a central role in hospital transfers.  Perhaps most importantly, the 
electronic health records that are becoming required in the United States are making the individual and 
composite outcomes of neurosurgeons transparent for evaluation, with far-reaching implications.  While 
many of these forces contribute to improve the care of neurological patients and thus should be 
celebrated by physicians worldwide, they nonetheless combine to undermine the autonomy enjoyed by 
neurosurgery. 
Traditionally, neurosurgery has been important to the business of medicine in ways that belies 
the size of our specialty.  Most of our diagnostic studies are costly.  Many of our patients require ICU 
care.  The mere availability of neurosurgical services is indispensable for the success of other medical 
specialties in the care of trauma patients.  Furthermore, our surgeries are very much driven by 
technology, resulting in tremendous opportunity for intellectual-properties focused business 
development.  Certainly in North America and in many other parts of the world, this financial relevance 
has held neurosurgery in good stead.  Even this is poised to change.  Consider spine surgery, for 
example, where intellectual-property driven development has had a major financial effect on 
neurosurgery.  Indeed, the development of spinal instrumentation and techniques in collaboration with 
industry is viewed by many as one of the success stories in our field.  As many of these patents expire, 
hospitals are now engaging in major supply-chain control efforts, where generic products may have 
almost all the features of brand-name products for far less cost, at least in the eyes of hospital 
administration.  Endovascular neurosurgery has also experienced similar influences and may ultimately 
need to address the same considerations.  Perhaps even more importantly, what is the role of 
neurosurgery in capitated healthcare delivery models, where our impact may have greater immediate 
relevance in discussions related to cost?  Will we continue to enjoy the unmitigated support of hospitals, 
health systems, and the medical economy? 
To face the challenges inherent to our discipline, neurosurgery has relied upon the 
incomparable esprit-de-corps that holds together neurosurgeons world-wide.  This is reflected in the 
sheer number of neurosurgical societies, organizations, and associations in the world.  The selection 
process to gain entry into the field as well as the arduous and lengthy training programs all serve to 
create a unique bond and kinship in neurosurgeons globally.  This has created a most cohesive medical 
fraternity, with virtually all neurosurgeons proud to consider themselves a member of this elite group.  
However, the past decade has witnessed a transformation in the nature of neurosurgery residency 
training in the United States.  Many countries in Western Europe experienced these changes even 
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earlier.  Resident work-hour regulations have required the increased reliance on physician extenders, 
and the sense of ownership of patients is arguably less among current residents.  While residency 
training governing bodies have reacted very effectively to these new considerations, and residency 
education is perhaps more structured and effective than ever, there is nevertheless a philosophical and 
generational gap that exists between neurosurgeons trained prior to these regulations and those trained 
under contemporary circumstances.  In modern practice in the United States, more and more 
neurosurgeons are working as hospital employees, a development that may further erode our personal 
equity ownership of our activities. 
While all of these developments seem to bode poorly for neurosurgery’s future, these winds of 
change may ultimately represent tremendous opportunity.  Most in leadership positions in our discipline 
recognize the plateau that has characterized the state of neurosurgery following the amazingly 
productive period catalyzed by the operating microscope and advanced imaging.  These two 
developments have combined to enable the establishment of modern microsurgery and minimally 
invasive techniques found ubiquitously in the world.  Without a doubt, neurosurgery continues to 
attract singularly talented young doctors, the lifeblood of any discipline and the envy of virtually all of 
the other medical specialties.  In addition, the training and practice of neurosurgery by its very nature 
endows the neurosurgeon with skills to conquer unique challenges with discipline and creativity.  In this 
consideration, our core strength is shifting from our technical abilities to our intellectual and personal 
qualities.  Recognizing this with appropriate shifts in emphasis, the field of neurosurgery may find even 
greater relevance in the new landscape of medicine.   
The key to this escalation of relevance, of course, lies in the direction and choices we make.  For 
example, as the conversation surrounding clinical neurosciences shifts from anatomy to function, 
neurosurgery has played a singular role historically in the restoration of function.  The correlation of 
function to anatomy has truly been one of our greatest contributions to the world.  Even today, the gold 
standard for identifying functional regions in the nervous system continues to be direct 
electrophysiological recordings, and neurosurgeons are the only physicians that are in position to 
perform such recordings in human beings.  The application of an external force to improve nervous 
system function through neuromodulation is uniquely neurosurgical.  Indeed, the targets and indications 
for neuromodulation are increasing rapidly in the cerebral cortex, deep brain structures, as well as in the 
spinal cord and peripheral nervous system.  Unlike many neurosurgical procedures, neuromodulation 
treatments are all driven by Class I data generated by clinical trials and successfully traversing the 
regulatory process.  However, conventional thinking must be challenged to overcome clear bottlenecks 
to widespread acceptance of concepts with demonstrated value.  For example, if we are to adhere to 
the strict definition of neuromodulation to require application of electrical forces through an invasive 
electrode, we would miss the potential of noninvasive strategies for neuromodulation offered by 
transcranial magnetic stimulation, or focused ultrasound.  There is no doubt that the invasive nature of 
current strategies poses a significant barrier with regard to patient choice, as well as to the future 
development of neuromodulation concepts, particularly in the harsh regulatory environment of medical 
devices.  Importantly, neurosurgeons must embrace a much broader definition of what is considered 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
neurosurgery, with scope to include the application of any external influence to the nervous system for 
therapeutic effect, however delivered. 
Neurosurgery can indeed play an increased role the evolution of clinical neurosciences, 
particularly as transformative technologies are developed to restore neurological function as a primary 
goal of treatment, and strategies are developed to address the overwhelming burden of neurological 
disease that fall outside the traditional scope of neurosurgery.  From genesis of concept to widespread 
utility in treating patients, a well-defined progression is necessary that can perhaps be considered to fall 
into three successive phases.  The first phase requires a new idea or discovery to be generated, typically 
in the laboratories of our universities or in the minds of transformative thinkers in the non-academic 
sector.  Ideally, the neurosurgeon plays a significant role in the development of the concept in 
collaboration with scientists and engineers to contribute the important perspective of patient need and 
indication.  Proof of concept involves the sequential progression from in-vitro studies to engineering a 
prototype for in-vivo demonstrations in an animal model, in some cases, non-human primates, a highly 
expensive proposition made even less palatable due to the absense of plans for ultimately treating the 
non-human primate.  Successful demonstration in non-human primates does not obviate the necessity 
of similar studies in human beings, where even greater costs and regulation are expected.  One way for 
neurosurgery to contribute to this bottleneck may be to take advantage of sequential “early-into-
humans” opportunities presented in the course of our standard-of-care treatment of patients.  An 
example may be the use of electrode grids for invasive EEG monitoring in epilepsy surgery for 
electrocorticograpy based brain machine interface studies.  In this way, no additional risk is undertaken 
by the patient other than in the standard-of-care treatment of epilepsy.  With strict oversight of the 
process in the interest of patient safety, this may allow for the sequential, low-risk development of 
concepts directly in humans in a process that cannot proceed without the neurosurgeon. 
The second phase after a human prototype is developed requires a large-scale clinical trial and 
navigating the regulatory process.  In this phase, partnerships between academic, government, and 
private sector entities are critical, where the combined expertise and resources of each may be 
synergized.  Typically, over $200 million and over a decade time may be necessary to bring a prototype 
to FDA approval in the United States.  Clearly, a transparent collaboration that engenders society’s trust 
is necessary to overcome this daunting barrier. 
The final phase to bring a new transformative technology or treatment to patients requires 
effective engagement of the disparate health systems found in the United States and all over the world.  
For neurosurgeons to have influence in this process, it is necessary for our direct participation in the 
administrative structures of public and private sector health systems, as well as in government and 
industry.  The heterogeneity of advanced care is grossly evident in public and private sector hospitals, 
urban and rural environments, as well as academic and community centers.  The ultimate impact of any 
transformative technology depends entirely on its widespread deployment and availability, an arena 
that requires influence by neurosurgeons in the political and administrative realm. 
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In sum, despite the tremendous changes that characterize the evolution of medicine world-
wide, neurosurgery remains well-positioned to flourish with ever-increasing relevance.  However, the 
field itself must evolve as well, in ways that may seem counterintuitive to conventional considerations.   
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